Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

with the saying: He who laughs last laughs best, writes Samuel Lagercrantz in an editorial.

Mathias Uhlén om kemipriset: ”Största nyttan är för förståelsen av människans biologi”

Årets Nobelpris i kemi gick till forskare som lyckats bygga och förutspå proteiners märkliga struktur. ”All medicinsk forskning har intresse för det här”, säger...

Conference on Alzheimer’s reveals several advances in the field

In Gothenburg, Sweden, researchers and pharmaceutical companies from all over the world gathered to discuss one specific issue – neurological diseases. Life Sci...

Collaboration in laboratory automation

The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...

Mastering Urine Microscopy: Techniques for Accurate Disease Detection

Live Webinar on September 25, 2024.

Nanexa develops depot formulation of the diabetes and obesity drug Saxenda

Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...

“Everyone is screaming for talent”

Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Hor...

Precision medicine centre: “Extensive activity on several fronts”

Two years ago, the Karolinska Institutet and the Karolinska University Hospital announced that they would jointly launch the Precision Medicine Centre. Medtech Magazine called Anna Wedell, who is heading the work, to find out…...

Astra Zenecas vd Pascal Soriot om Kina: ”Väldigt öppet”

Astra Zenecas vd Pascal Soriot hyllade Kina som ”väldigt öppet” och ”välkomnande” under ett event i Peking i helgen.

Integrated solutions for liquid handling

Greater efficiency for manufacturers in laboratory automation and many other industries

Rapid development in blood analysis – “Sweden is leading the race”

Thousands of analytical tests using just one single drop of blood. What was revealed as a hoax just a few years ago is now a reality, according to KTH professor...

ProPharma

Medicon Valley Alliance

Sex nya innovationsmiljöer ska utveckla precisionsmedicin

Vinnova anslår 95 miljoner kronor till sex nya innovationsmiljöer med inriktning på precisionmedicin.

Controlled Pneumatics: pushing the boundaries of pneumatics

automation processes that are already known. It also opens up new opportunities, especially for controlling pressure and flow rate. Piezo valves, which enable v...

He saved lives with his theories – was ostracised and ended up in a mental hospital

Hungarian doctor Ignaz Semmelweis (1818-1865) undoubtedly possessed plenty of persistence, diligence and sound reasoning skills – but he was hardly blessed with...

“We aim to be a start-up company with an academic spirit”

Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working...

Marie Gårdmark: New incentives for orphan products on its way

"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...

Återfinn julefriden – med Life Science Sweden

Nu tar redaktionen julledigt, men passar på att påminna om några artiklar från hösten som du kanske missade. Vi önskar alla läsare en god jul, och är tillbaka den 7 januari.

Vd-skifte på Hamlet Biopharma

Hamlet Biopharma utser tidigare styrelseordföranden Catharina Svanborg till ny vd. Hon ersätter Martin Erixon som lämnar bolaget med omedelbar verkan.

Meeting with focus on South Korea and Japan’s life sciences

Large, complex and exciting – this is how Britta Stenson, Business Sweden, describes the life science markets of Japan and South Korea, which took centre stage ...

BioArctic moves forward with its candidate for Parkinson’s

BioArctic announces positive early phase study results for its drug candidate for Parkinson’s disease.

Nordic Regulatory experts: Improving biotech chances of Succ

Why is it that so many biotech companies fail? And what are the tools needed to change that fact?

Webinar: Automate your processes

Free ZEISS webinar on January 30th, 2025.